ADAPTIVE BIOTECHNOLOGIES CORPORATION - COMMON STOC

Adaptive Biotechnologies Included in More than 20 Abstracts at ASCO and EHA 2021 Highlighting Expanding Use Cases for MRD Testing with the clonoSEQ® Assay in Blood Cancer Patients

03 Jun 2021 07:30:00 By Nasdaq GlobeNewswire

Adaptive Biotechnologies to Participate in Upcoming June 2021 Investor Conferences

20 May 2021 16:05:00 By Nasdaq GlobeNewswire

Adaptive Biotechnologies Reports First Quarter 2021 Financial Results

05 May 2021 16:05:01 By Nasdaq GlobeNewswire

Adaptive Biotechnologies to Present at the BofA Securities 2021 Virtual Healthcare Conference

27 Apr 2021 16:05:01 By Nasdaq GlobeNewswire

Adaptive Biotechnologies to Report First Quarter Financial Results on May 5, 2021

12 Apr 2021 16:05:00 By Nasdaq GlobeNewswire

Adaptive Biotechnologies Strengthens Expertise and Diversity of Board of Directors with Appointments of Leslie Trigg and Katey Owen

17 Mar 2021 16:05:00 By Nasdaq GlobeNewswire

Adaptive Biotechnologies Announces FDA Emergency Use Authorization for T-Detect™ COVID to Confirm Recent or Prior COVID-19 Infection

05 Mar 2021 18:44:52 By Nasdaq GlobeNewswire

Adaptive Biotechnologies to Present at the Cowen 41st Annual Healthcare Conference

25 Feb 2021 16:05:01 By Nasdaq GlobeNewswire

Adaptive Biotechnologies Reports Fourth Quarter and Full Year 2020 Financial Results

24 Feb 2021 16:05:01 By Nasdaq GlobeNewswire

Adaptive Biotechnologies Expands Collaboration with Labcorp to Increase Access to Growing Research and Clinical Diagnostic Portfolio

23 Feb 2021 09:15:00 By Nasdaq GlobeNewswire

Adaptive Biotechnologies Launches T-Detect™ COVID, First Clinical T-Cell Based Test for Patients to Confirm Recent or Prior COVID-19 Infection

23 Feb 2021 07:30:00 By Nasdaq GlobeNewswire

Adaptive Biotechnologies to Report Fourth Quarter and Full Year 2020 Financial Results on February 24, 2021

02 Feb 2021 16:05:00 By Nasdaq GlobeNewswire

Adaptive Biotechnologies to Collaborate with AstraZeneca in Mapping the Immune Response to Cancer Antigens to Potentially Inform the Development of Novel Diagnostics and Therapeutics

11 Jan 2021 16:01:00 By Nasdaq GlobeNewswire